ENPP-2

ENPP-2

ENPP-2 詳細

Molecule Name
Ectonucleotide pyrophosphatase/phosphodiesterase 2
分子の別称
ENPP-2,E-NPP 2,Autotaxin,LysoPLD,ATX,PDNP2,ATX-X,NPP2,PD-IALPHA
Drug Development Progress
治験薬の数9
市販薬剤の数0
研究&開発段階Phase 2 Clinical
ターゲットの別称
EC:3.1.4.39,ATX,Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2,Phosphodiesterase I/Nucleotide Pyrophosphatase 2,Plasma Lysophospholipase D,Autotaxin-T,EC 3.1.4.39,PD-IALPHA,ATX-X,NPP2,E-NPP 2,Autotaxin,ENPP2,PDNP2,Ectonucleotide Pyrophosphatase/Phosphodiesterase 2,Extracellular Lysophospholipase D,LysoPLD
バックグランド
Autotaxin also known as ectonucleotide pyrophosphatase / phosphodiesterase family member 2 (E-NPP 2 or ENPP2), Extracellular lysophospholipase D (LysoPLD), Autotaxin (ATX or ATX-X), which belongs to the nucleotide pyrophosphatase / phosphodiesterase family. ENPP2 contains two SMB (somatomedin-B) domains. ENPP2 hydrolyzes lysophospholipids to produce lysophosphatidic acid (LPA) in extracellular fluids. ENPP2 can act on sphingosylphosphphorylcholine producing sphingosine-1-phosphate, a modulator of cell motility. ENPP2 stimulates migration of melanoma cells, probably via a pertussis toxin-sensitive G protein.

ENPP-2 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
BBT-877BBT-877Phase 2 ClinicalLegochem
Idiopathic Pulmonary Fibrosis
詳細
CambritaxestatCRT-0273750; IOA-289Phase 2 ClinicalCancer Research Technology, Merck & Co
Pancreatic Neoplasms; Solid tumours
詳細
HRS-9813HRS-9813; HRS9813Phase 2 ClinicalGuangdong Hengrui Pharmaceutical Co Ltd
Idiopathic Pulmonary Fibrosis; Pulmonary Fibrosis
詳細
HW-021199HW-021199Phase 2 ClinicalHubei Bio-Pharmaceutical Industrial Technological Institute Inc, Humanwell Puracap (Likang) Pharmaceuticals Co Ltd
Idiopathic Pulmonary Fibrosis
詳細
HNC664HNC664; HNC-664Phase 1 ClinicalGuangzhou Henovcom Bioscience Co Ltd
Idiopathic Pulmonary Fibrosis; Pancreatic Neoplasms
詳細
CudetaxestatPAT-409; BLD-0409Phase 1 ClinicalBlade Therapeutics Inc
Idiopathic Pulmonary Fibrosis; Liver Diseases; Metabolic Dysfunction-Associated Steatotic Liver Disease
詳細
NXC-680NXC-680Phase 1 ClinicalNextgen Bioscience Inc
Idiopathic Pulmonary Fibrosis
詳細
HNC-1058HNC-1058Phase 1 ClinicalGuangzhou Henovcom Bioscience Co Ltd
Idiopathic Pulmonary Fibrosis
詳細
FTP-198FTP-198Phase 1 ClinicalHaisco Pharmaceutical Group Co Ltd
Idiopathic Pulmonary Fibrosis
詳細